Genetics in ocular inflammation-basic principles

Ocular Immunology and Inflammation

Volumn 19, Issue 1, 2011, Pages 10-18

  Wallace, G R ^a   Niemczyk, E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

genetics; ocular inflammation

Indexed keywords

DNA; HLA A ANTIGEN; HLA A29 ANTIGEN; HLA B27 ANTIGEN; HLA B51 ANTIGEN; HLA DR1 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 25; MICRORNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BEHCET DISEASE; CHORIORETINOPATHY; DNA METHYLATION; DNA MICROARRAY; EYE INFLAMMATION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; IRIDOCYCLITIS; MOLECULAR CLONING; MONOGENIC DISORDER; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; RETINA VASCULITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPATHETIC OPHTHALMIA; UVEITIS; VOGT KOYANAGI SYNDROME;

BEHCET SYNDROME; EYE DISEASES; FEMALE; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HLA ANTIGENS; HUMANS; INFLAMMATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 79952827459     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.543306     Document Type: Article

References (68)

1. Antoniou AC, Chenevix-Trench G. Common genetic variants and cancer risk in Mendelian cancer syndromes. Curr Opin Genet Dev. Jun 2010;20(3):299-307.
2. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol. Aug 2005;14(3-4):175-182. (Pubitemid 40848523)
3. Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen Am J Ophthalmol. Aug 1982;94(2):147-158. (Pubitemid 12038546)
4. Bonfoli AA, Orefce F. Behcets disease. Semin Ophthalmol. Jul-Sep 2005;20(3):199-206.
5. Chang JH, McCluskey PJ, Wakefeld D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. Jul-Aug 2005;50(4):364-388. (Pubitemid 40828227)
6. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. Jan 1997;123(1):70-75. (Pubitemid 27044563)
7. Kilmartin DJ, Wilson D, Liversidge J, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol. Mar 2001;85(3):281-286. (Pubitemid 32250755)
8. Cuccia Belvedere M, Martinetti M, de Paoli F, et al. Genetic heterogeneity in uveitis. Dis Markers. Oct 1986;4(3):243-246. (Pubitemid 17206532)
9. Szpak Y, Vieville JC, Tabary T, et al. Spontaneous retinopa-thy in HLA-A29 transgenic mice. Proc Natl Acad Sci USA. Feb 27 2001;98(5):2572-2576. (Pubitemid 32209523)
10. Pennesi G, Mattapallil MJ, Sun SH, et al. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest. Apr 2003;111(8):1171-1180. (Pubitemid 36519934)
11. Mandeville JT, Levinson RD, Holland GN. The tubuloint-erstitial nephritis and uveitis syndrome. Surv Ophthalmol. Nov-Dec 2001;46(3):195-208.
12. Gorrono-Echebarria MB, Calvo-Arrabal MA, Albarran F, Alvarez-Mon M. The tuberculointerstitial nephri-tis and uveitis (TINU) syndrome is associated with HLA-DR14 in Spanish patients. Br J Ophthalmol. Aug 2001;85(8):1010-1011. (Pubitemid 32706182)
13. Levinson RD, Park MS, Rikkers SM, et al. Strong associa-tions between specifc HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. Feb 2003;44(2):653-657. (Pubitemid 36159711)
14. Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada dis-ease. Semin Ophthalmol. Jul-Sep 2005;20(3):183-190.
15. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behcet′s disease. Arch Ophthalmol. Sep 1982;100(9):1455-1458. (Pubitemid 12055531)
16. Ota M, Mizuki N, Katsuyama Y, et al. The critical region for Behcet disease in the human major histocompatibility com-plex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refned microsatellite map-ping. Am J Hum Genet. May 1999;64(5):1406-1410. (Pubitemid 30468760)
17. Mizuki N, Ota M, Yabuki K, et al. Localization of the patho-genic gene of Behcet′s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. Nov 2000;41(12):3702-3708.
18. Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behcet′s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. Mar 2003;48(3):807-813. (Pubitemid 36302019)
19. Gul A, Uyar FA, Inanc M, et al. A weak association of HLA-B*2702 with Behcet's disease. Genes Immun. Sep 2002;3(6):368-372. (Pubitemid 38967565)
20. Gao X, O'Brien TR, Welzel TM, et al. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS. Jul 31 2010;24(12):1835-1840.
21. Feitsma AL, Worthington J, van der Helm-van Mil AH, et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc Natl Acad Sci USA. Dec 11 2007;104(50):19966-19970.
22. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet′s disease, the Silk Road and HLA-B51: histori-cal and geographical perspectives. Tissue Antigens. Sep 1999;54(3):213-220. (Pubitemid 29443840)
23. Sfkakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infiximab on sight-threatening panuveitis in Behcet′s disease. Lancet. Jul 28 2001;358(9278):295-296. (Pubitemid 32738970)
24. El-Shabrawi Y, Wegscheider BJ, Weger M, et al. Polymorphisms within the tumor necrosis factor-alpha pro-moter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology. Apr 2006;113(4):695-700.
25. Kuo NW, Lympany PA, Menezo V, et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci. May 2005;46(5):1565-1571. (Pubitemid 44843587)
26. Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A. Association of specifc interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet′s disease. Rheumatology (Oxford). Jul 2003;42(7):860-864. (Pubitemid 37220935)
27. Stanford MR, Vaughan RW, Kondeatis E, et al. Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol. Aug 2005;89(8):1013-1016. (Pubitemid 41081415)
28. Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens. Jan 2004;63(1):41-45. (Pubitemid 38130441)
29. Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene poly-morphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci. Nov 2005;46(11):4245-4250. (Pubitemid 44264628)
30. Wallace GR, Kondeatis E, Vaughan RW, et al. IL-10 genotype analysis in patients with Behcet′s disease. Hum Immunol. Feb 2007;68(2):122-127. (Pubitemid 46282216)
31. Atan D, Fraser-Bell S, Plskova J, et al. Cytokine polymor-phism in noninfectious uveitis. Invest Ophthalmol Vis Sci. Aug 2010;51(8):4133-4142.
32. Broeckel U, Schork NJ. Identifying genes and genetic varia-tion underlying human diseases and complex phenotypes via recombination mapping. J Physiol. Jan 1 2004;554(Pt 1):40-45. (Pubitemid 38081440)
33. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. Jul 8 2010;363(2):166-176.
34. Hindorff LA JH, Hall PN, Mehta JP, and Manolio TA. A Catalog of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies. Accessed [07/10/2010].
35. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identifcation of novel genetic susceptibility loci for Behcet′s disease using a genome-wide association study Arthritis Res Ther. 2009;11(3):R66.
36. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide associa-tion study identifes variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet′s disease. Nat Genet. Aug 2010;42(8):698-702.
37. Kurata R, Nakaoka H, Tajima A, et al. TRIM39 and RNF39 are associated with Behcet′s disease independently of HLA-B *51 and-A *26. Biochem Biophys Res Commun. Sep 27 2010.
38. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet′s disease susceptibility loci. Nat Genet. Aug 2010;42(8):703-706.
39. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in infamma-tion. J Clin Invest. May 2006;116(5):1218-1222.
40. Paunovic V Carroll HP, Vandenbroeck K, Gadina M. Signalling, infammation and arthritis: crossed signals: the role of interleukin (IL)-12,-17,-23 and-27 in autoimmunity Rheumatology (Oxford). Jun 2008;47(6):771-776. (Pubitemid 351796359)
41. Hollyfeld JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced infammation initiates age-related macular degeneration. Nat Med. Feb 2008;14(2):194-198. (Pubitemid 351214555)
42. Hageman GS, Anderson DH, Johnson LV, et al. A com-mon haplotype in the complement regulatory gene fac-tor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. May 17 2005;102(20):7227-7232. (Pubitemid 40696361)
43. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. Apr 15 2005;308(5720):385-389. (Pubitemid 40530070)
44. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related macu-lopathy on chromosome 10q26. Am J Hum Genet. Sep 2005;77(3):389-407. (Pubitemid 41192646)
45. McKay GJ, Dasari S, Patterson CC, Chakravarthy U, Silvestri G. Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol Vis. 2010;16:194-199.
46. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specifc disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, infammatory disease. Arthritis Rheum. Jan 2005;52(1):269-274. (Pubitemid 40129257)
47. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide asso-ciation study identifes new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. May 2007;39(5):596-604. (Pubitemid 46676115)
48. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. Jan 2009;10(1):43-55.
49. Baranathan V, Stanford MR, Vaughan RW, et al. The asso-ciation of the PTPN22 620W polymorphism with Behcets disease. Ann Rheum Dis. Nov 2007;66(11):1531-1533. (Pubitemid 350032665)
50. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide asso-ciation defnes more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. Aug 2008;40(8):955-962.
51. Bye L, Modi N, Stanford MR, et al. CTLA-4 polymorphisms are not associated with ocular infammatory disease. Tissue Antigens. Jul 2008;72(1):49-53. (Pubitemid 351841648)
52. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. Jun 7 2007;447(7145):661-678.
53. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. Dec 1977;74(12):5463-5467
54. Hutchison CA, 3rd. DNA sequencing: bench to bedside and beyond. Nucleic Acids Res. 2007;35(18):6227-6237
55. Ansorge WJ. Next-generation DNA sequencing techniques. N Biotechnol. Apr 2009;25(4):195-203.
56. Schuster SC. Next-generation sequencing transforms today's biology Nat Methods. Jan 2008;5(1):16-18.
57. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet. Jan 2010;11(1):31-46.
58. Li Z, Liu B, Maminishkis A, et al. Gene expression profling in autoimmune noninfectious uveitis disease. J Immunol. Oct 1 2008;181(7):5147-5157.
59. Shanley DP, Aw D, Manley NR, Palmer DB. An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. Jul 2009;30(7):374-381.
60. Panda A, Arjona A, Sapey E, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. Jul 2009;30(7):325-333.
61. Williams GC Pleiotropy, natural selection and the evolution of senescence. Evolution. 1957;11:398-411.
62. Ferwerda B, Alonso S, Banahan K, et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci USA. Jun 23 2009;106(25):10272-10277.
63. Dieker J, Muller S. Epigenetic histone code and autoimmunity Clin Rev Allergy Immunol. Aug 2010;39(1):78-84.
64. Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451-481.
65. Moore JH, Williams SM. Epistasis and its implications for personal genetics. Am J Hum Genet. Sep 2009;85(3):309-320.
66. Ferwerda B, McCall MB, Alonso S, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA. Oct 16 2007;104(42):16645-16650. (Pubitemid 350211070)
67. Mitchison NA, Muller B, Segal RM. Natural variation in immune responsiveness, with special reference to immunodefciency and promoter polymorphism in class II MHC genes. Hum Immunol. Feb 2000;61(2):177-181. (Pubitemid 30075241)
68. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature. Apr 29 2010;464(7293):1351-1356.